Waisman Biomanufacturing Partners with Heat Biologics on COVID-19 Vaccine Manufacture
Read the full press release here Waisman Biomanufacturing at the University of Wisconsin partnered with Heat Biologics to produce a COVID-19 vaccine for Phase I and Phase II clinical trials. Phase I trials could begin in early 2021, and UW–Madison…